Cas9/gRNA-mediated genome editing of yeast mitochondria and

CRISPR Cas9/gRNA Chlamydomonas Chloroplast DNA replacement Edit Plasmid Genome editing Mitochondria Organelle Yeast

Journal

PeerJ
ISSN: 2167-8359
Titre abrégé: PeerJ
Pays: United States
ID NLM: 101603425

Informations de publication

Date de publication:
2020
Historique:
received: 16 10 2018
accepted: 05 12 2019
entrez: 15 1 2020
pubmed: 15 1 2020
medline: 15 1 2020
Statut: epublish

Résumé

We present a new approach to edit both mitochondrial and chloroplast genomes. Organelles have been considered off-limits to CRISPR due to their impermeability to most RNA and DNA. This has prevented applications of Cas9/gRNA-mediated genome editing in organelles while the tool has been widely used for engineering of nuclear DNA in a number of organisms in the last several years. To overcome the hurdle, we designed a new approach to enable organelle genome editing. The plasmids, designated "Edit Plasmids," were constructed with two expression cassettes, one for the expression of Cas9, codon-optimized for each organelle, under promoters specific to each organelle, and the other cassette for the expression of guide RNAs under another set of promoters specific to each organelle. In addition, Edit Plasmids were designed to carry the donor DNA for integration between two double-strand break sites induced by Cas9/gRNAs. Each donor DNA was flanked by the regions homologous to both ends of the integration site that were short enough to minimize spontaneous recombination events. Furthermore, the donor DNA was so modified that it did not carry functional gRNA target sites, allowing the stability of the integrated DNA without being excised by further Cas9/gRNAs activity. Edit Plasmids were introduced into organelles through microprojectile transformation. We confirmed donor DNA insertion at the target sites facilitated by homologous recombination only in the presence of Cas9/gRNA activity in yeast mitochondria and

Identifiants

pubmed: 31934513
doi: 10.7717/peerj.8362
pii: 8362
pmc: PMC6951285
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e8362

Informations de copyright

© 2020 Yoo et al.

Déclaration de conflit d'intérêts

Hajime Sakai is CEO at Napigen. Byung-Chun Yoo, Narendra Yadav and Emil Orozco, Jr are employees at Napigen. All authors are co-inventors on patent application US2019/0136249 A1 “organelle genome modification using polynucleotide guided endonuclease,” submitted by Napigen. The authors declare that they have no other competing interests.

Références

Science. 2018 Sep 28;361(6409):1302
pubmed: 30262479
Plant J. 2018 Feb;93(3):545-565
pubmed: 29172250
Sci Rep. 2016 Nov 24;6:37895
pubmed: 27883076
J Biotechnol. 2015 Feb 10;195:60-6
pubmed: 25554634
Front Plant Sci. 2016 Feb 04;7:57
pubmed: 26870072
J Biol Chem. 2001 Mar 2;276(9):6392-7
pubmed: 11106667
Plant J. 2002 Jun;30(6):733-44
pubmed: 12061904
Biotechnol Bioeng. 2012 Nov;109(11):2896-903
pubmed: 22674415
Microbiology. 2009 Jan;155(Pt 1):268-78
pubmed: 19118367
Front Biosci (Landmark Ed). 2017 Jan 1;22:920-943
pubmed: 27814655
Plant Cell. 2011 Nov;23(11):3992-4012
pubmed: 22128124
Plant Biotechnol J. 2011 Jun;9(5):565-74
pubmed: 20809927
Nat Biotechnol. 2013 Apr;31(4):335-41
pubmed: 23417095
Nat Biotechnol. 2014 Nov;32(11):1141-5
pubmed: 25240928
Proc Natl Acad Sci U S A. 1979 Dec;76(12):6534-8
pubmed: 230513
Plant J. 2009 Feb;57(3):436-45
pubmed: 18939966
Trends Plant Sci. 2015 Oct;20(10):622-640
pubmed: 26440432
Plant J. 2008 Mar;53(5):842-53
pubmed: 18036204
Photosynth Res. 2004 Feb;79(2):219-24
pubmed: 16228396
Genome Biol. 2016 Jul 05;17(1):148
pubmed: 27380939
Science. 1988 Jun 10;240(4858):1534-8
pubmed: 2897716
Proc Natl Acad Sci U S A. 1988 Oct;85(19):7288-92
pubmed: 2459701
Nat Rev Genet. 2002 Jun;3(6):475-81
pubmed: 12042774
FEBS Lett. 1998 Dec 4;440(3):325-31
pubmed: 9872396
Nucleic Acids Res. 2000 Jan 1;28(1):292
pubmed: 10592250
Methods Mol Biol. 2014;1132:391-9
pubmed: 24599869
Plant J. 2016 Jul;87(1):87-102
pubmed: 27005523
Sci Rep. 2016 Jun 13;6:27810
pubmed: 27291619
Biotechnology (N Y). 1995 Apr;13(4):362-5
pubmed: 9634777
Proc Natl Acad Sci U S A. 1976 Oct;73(10):3651-5
pubmed: 790391
Mol Cell. 2018 Jun 7;70(5):801-813.e6
pubmed: 29804829
Cell. 1988 Mar 25;52(6):903-13
pubmed: 3280139
Methods Mol Biol. 2011;684:313-20
pubmed: 20960138
Front Plant Sci. 2018 Jul 17;9:985
pubmed: 30065734
Plant Physiol. 2015 Oct;169(2):960-70
pubmed: 26294043
Front Plant Sci. 2018 Mar 01;9:183
pubmed: 29545812
Mol Cell Biol. 1993 Aug;13(8):4806-13
pubmed: 8393138
Eukaryot Cell. 2014 Nov;13(11):1465-9
pubmed: 25239977
Methods Mol Biol. 2007;372:153-66
pubmed: 18314724
PLoS One. 2013 Oct 15;8(10):e78105
pubmed: 24143261
Plant J. 2014 Dec;80(5):915-25
pubmed: 25234691
Proc Natl Acad Sci U S A. 1990 Nov;87(21):8526-30
pubmed: 11607112
Nat Plants. 2019 Jul;5(7):722-730
pubmed: 31285556
Mitochondrion. 2001 Aug;1(2):181-9
pubmed: 16120277
Plant Cell. 2004;16 Suppl:S154-69
pubmed: 15131248
Plant Physiol. 2004 Dec;136(4):4048-60
pubmed: 15563620
mBio. 2014 Jan 28;5(1):e00928-13
pubmed: 24473129
Mol Genet Genomics. 2003 Oct;270(1):1-8
pubmed: 12928865
Proc Natl Acad Sci U S A. 2010 Aug 3;107(31):13954-9
pubmed: 20643920
J Cell Biol. 1999 May 17;145(4):659-72
pubmed: 10330397
J Biosci Bioeng. 2003;95(3):276-82
pubmed: 16233405
Mol Gen Genet. 2000 Jan;262(6):1036-46
pubmed: 10660064
Science. 2013 Feb 15;339(6121):819-23
pubmed: 23287718
Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):3570-5
pubmed: 25733849
Mol Plant Microbe Interact. 2017 Oct;30(10):829-841
pubmed: 28703028
Biomed Res Int. 2015;2015:305716
pubmed: 26448933
Mol Plant. 2013 Nov;6(6):1975-83
pubmed: 23956122
AMB Express. 2014 Aug 13;4:57
pubmed: 25136510

Auteurs

Byung-Chun Yoo (BC)

NAPIGEN, Inc., Wilmington, DE, USA.

Narendra S Yadav (NS)

NAPIGEN, Inc., Wilmington, DE, USA.

Emil M Orozco (EM)

NAPIGEN, Inc., Wilmington, DE, USA.

Hajime Sakai (H)

NAPIGEN, Inc., Wilmington, DE, USA.

Classifications MeSH